Physicochemical characterization of nedocromil bivalent metal salt hydrates. 2. Nedocromil zinc

Journal of Pharmaceutical Sciences

Volumn 86, Issue 4, 1997, Pages 418-429

  Zhu, Haijian ^a   Padden, Brian E ^b   Munson, Eric J ^b   Grant, David J W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METAL; NEDOCROMIL SODIUM; ZINC CHLORIDE;

AQUEOUS SOLUTION; ARTICLE; CRYSTAL STRUCTURE; DESICCATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; HYDRATION; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSTRUCTIVE AIRWAY DISEASE; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY; TITRIMETRY; X RAY DIFFRACTION;

EID: 0030975430     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9604422     Document Type: Article

References (27)

1. Berge, S. M.; Bighley, S. D; Monkhouse, D. C. Pharmaceutical salts. J. Pharm. Sci. 1977, 66, 1-19.
2. Gould, P. L. Salt selection for basic drugs. Int. J. Pharm. 1986, 33, 201-217.
3. Hirsch, C. A.; Messenger, R. J.; Brannon, J. L. Fenoprofen: Drug form selection and preformulation stability studies. J. Pharm. Sci. 1978, 67, 231-236.
4. Forbes, R. T.; York, P.; Fawcett, V.; Shields, L. Physicochemical properties of salts of p-aminosalicylic acid. I. Correlation of crystal structure and hydrate stability. Pharm. Res. 1992, 9, 1428-1435.
5. Cairns, H.; Cox, D.; Gould, K. J.; Ingall, A. H.; Suschitzky, J. L. New antiallergic pyrano[3,2-g]quinoline-2,8-dicarboxylic acids with potential for the tropical treatment of asthma. J. Med. Chem. 1985, 28, 1832-1842.
6. Zhu, H.; Khankari, R. K.; Padden, B. E.; Munson, E. J.; Gleason, W. B.; Grant, D. J. W. Physicochemical characterization of nedocromil bivalent metal salt hydrates: 1. Nedocromil Magnesium. J. Pharm Sci. 1996, 85, 1026-1034.
7. Ojala, W. H.; Khankari, R. K.; Grant, D. J. W.; Gleason, W. B. Crystal structures and physical chemical properties of nedocromil zinc heptahydrate and nedocromil magnesium pentahydrate. J. Chem. Crystallogr. 1996, 26, 167-178.
8. Zhu, H.; Poon, W.; Leung, S.; Li, Z. J.; Grant, D. J. W.; Padden, B. E.; Thakur, K. A.M.; Munson, E. J. Solid-state NMR studies of pharmaceuticals. Poster Presentation at the Experimental NMR Conference, Pacific Grove, CA, March 17-22, 1996.
9. Ostwald, W. Lehrbuch der Algemeinen Chemie 2; Englemann: Leipzig, 1896; p 444.
10. Nyquist, H. Saturated salt solutions for maintaining specified relative humidities. Int. J. Pharm. Tech. Prod. Mfr. 1983, 4, 47-48.
11. Collett, J. H.; Rees, J. A.; Dickinson, N. A. Some parameters describing the dissolution rate of salicylic acid at controlled pH. J. Pharm. Pharmacol. 1972, 24, 724-728.
12. Doherty, C.; York, P., Mechanisms of dispersion of frusemide/ PVP solid dispersions. Int. J. Pharm. 1987, 34, 197-205.
13. Chan, H.; Venkataram, S.; Grant, D. J. W.; Rahman, Y-E. Crystal structures of a new oral iron chelator 1, 2-dimethyl-3-hydroxy-4-pyridone, and its solvates with acetic acid and formic acid. J. Pharm. Sci. 1991, 80, 677-685.
14. Ghosh, S.; Adsmond, D. A.; Grant, D. J. W. Relationships between solution thermodynamics and hydrogen-bond patterns of crystalline dialkylhydroxypyridone iron chelators and their formic acid solvates. J. Pharm. Sci. 1995, 84, 568-574.
15. Jozwiakowski, M. J.; Williams, S. O.; Hathaway R. D. Relative physical stability of the solid forms of amiloride HCl. Int. J. Pharm. 1993, 91, 195-207.
16. Khankari, R; Grant, D. J. W. Solution mediated transformation of nedocromil sodium heptahemihydrate to nedocromil sodium trihydrate. Pharm. Res. 1994, 11, S-241.
17. Wright, J. D. Molecular Crystals, 2nd ed.; Cambridge University: Cambridge, U.K., 1995; pp 22-49.
18. TEXSAN-TEXRAY Structure Analysis Package, Molecular Structure Corporation, 3200 Research Forest Drive, The Woodlands, TX, 1985.
19. 13C NMR. J. Magn. Reson. 1982, 49, 341-345.
20. Dixon, W. T. Spinning-sideband-free and spinning-sideband only NMR spectra in spinning samples. J. Chem. Phys. 1982, 77, 1800.
21. Khankari, R. K.; Ojala, W. H.; Gleason, W. B.; Grant, D. J. W. Crystal structure of nedocromil sodium heptahemihydrate and its comparison with that of nedocromil sodium trihydrate. J. Chem. Crystallogr. 1995, 25, 859-866.
22. Noyes, A. A.; Whitney, W. R. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 1897, 19, 930-934.
23. Shefter, E.; Higuchi, T. Dissolution behavior of crystalline solvated and nonsolvated forms of some pharmaceuticals. J. Pharm. Sci. 1963, 52, 781-791.
24. Topping, J. Errors of Observation and their Treatment, 3rd ed.; Chapman and Hall: London, 1962; p 82.
25. Threlfall, T. L. Analysis of organic polymorphs - A review. Analyst 1995, 120, 2435-2460.
26. Allen, P. V.; Rahn, P. D.; Sarapu, A. C.; Vanderwielen, A. J. Physical characterization of erythromycin: anhydrate, monohydrate, and dihydrate crystalline solids. J. Pharm. Sci. 1978, 8, 1087-1093.
27. Wu, L-S.; Gerard, C.; Koval, C.; Rowe, S.; Hussain, M. A. Crystallinity, hygroscopicity and dissolution of moricizine hydrochloride hemihydrate. J. Pharm. Biomed. Anal. 1994, 10, 1043-1046.